204 related articles for article (PubMed ID: 10426821)
1. Development of resistance during the early stages of experimental liver carcinogenesis.
Yusuf A; Rao PM; Rajalakshmi S; Sarma DS
Carcinogenesis; 1999 Aug; 20(8):1641-4. PubMed ID: 10426821
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital.
Manjeshwar S; Laconi E; Sheikh A; Rao PM; Rajalakshmi S; Sarma DS
Carcinogenesis; 1994 Sep; 15(9):1963-8. PubMed ID: 7923591
[TBL] [Abstract][Full Text] [Related]
3. 2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism.
Saeter G; Schwarze PE; Nesland JM; Seglen PO
Carcinogenesis; 1988 Apr; 9(4):581-7. PubMed ID: 2895691
[TBL] [Abstract][Full Text] [Related]
4. Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats.
Wood GA; Sarma DS; Archer MC
Carcinogenesis; 1999 Jul; 20(7):1169-75. PubMed ID: 10383886
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats.
Tiwawech D; Hasegawa R; Kurata Y; Tatematsu M; Shibata MA; Thamavit W; Ito N
Carcinogenesis; 1991 Jun; 12(6):985-90. PubMed ID: 2044205
[TBL] [Abstract][Full Text] [Related]
6. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci.
Wood GA; Korkola JE; Lee VM; Sarma DS; Archer MC
Carcinogenesis; 1997 Sep; 18(9):1745-50. PubMed ID: 9328170
[TBL] [Abstract][Full Text] [Related]
7. Induced drug resistance inhibits selection of initiated cells and cancer development.
Rissler P; Torndal UB; Eriksson LC
Carcinogenesis; 1997 Apr; 18(4):649-55. PubMed ID: 9111195
[TBL] [Abstract][Full Text] [Related]
8. Analysis of calcium-dependent protein kinase C isoforms in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis.
La Porta CA; Perletti GP; Piccinini F; Comolli R
Mol Carcinog; 1993; 8(4):255-63. PubMed ID: 7904165
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis.
La Porta CA; Comolli R
Carcinogenesis; 1995 May; 16(5):1233-8. PubMed ID: 7767990
[TBL] [Abstract][Full Text] [Related]
10. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
[TBL] [Abstract][Full Text] [Related]
11. An earlier proliferative response of hepatocytes in gamma-glutamyl transferase positive foci to partial hepatectomy.
Laconi E; Vasudevan S; Rao PM; Rajalakshmi S; Pani P; Sarma DS
Cancer Lett; 1994 Jun; 81(2):229-35. PubMed ID: 7912165
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
[TBL] [Abstract][Full Text] [Related]
13. Sex-differentiated and growth-hormone-regulated mitoinhibition in rat liver during treatment with 2-acetylaminofluorene and partial hepatectomy in the resistant hepatocyte model.
Blanck A; Eriksson LC; Gustafsson JA; Porsch Hällström I
Carcinogenesis; 1991 Jul; 12(7):1259-64. PubMed ID: 2070491
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and c-met mRNAs during rat chemically induced hepatocarcinogenesis.
Imai T; Masui T; Nakanishi H; Inada K; Kobayashi K; Nakamura T; Tatematsu M
Carcinogenesis; 1996 Jan; 17(1):19-24. PubMed ID: 8565131
[TBL] [Abstract][Full Text] [Related]
15. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats.
Dragan YP; Campbell HA; Xu XH; Pitot HC
Carcinogenesis; 1997 Jan; 18(1):149-58. PubMed ID: 9054601
[TBL] [Abstract][Full Text] [Related]
16. Studies on liver tumor promotion in the rat by orotic acid: dose and minimum exposure time required for dietary orotic acid to promote hepatocarcinogenesis.
Laconi E; Denda A; Rao PM; Rajalakshmi S; Pani P; Sarma DS
Carcinogenesis; 1993 Sep; 14(9):1771-5. PubMed ID: 8403198
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different initiation protocols in the resistant hepatocyte model.
Espandiari P; Robertson LW; Srinivasan C; Glauert HP
Toxicology; 2005 Jan; 206(3):373-81. PubMed ID: 15588927
[TBL] [Abstract][Full Text] [Related]
18. The variations of S-adenosyl-L-methionine content modulate hepatocyte growth during phenobarbital promotion of diethylnitrosamine-induced rat liver carcinogenesis.
Feo F; Garcea R; Pascale R; Pirisi L; Daino L; Donaera A
Toxicol Pathol; 1987; 15(1):109-14. PubMed ID: 2883718
[TBL] [Abstract][Full Text] [Related]
19. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
[TBL] [Abstract][Full Text] [Related]
20. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
